Ekkehard Schütz
Chief Tech/Sci/R&D Officer bij ONCOCYTE CORPORATION
Profiel
Dr. Ekkehard Schütz is a Chief Science Officer at OncoCyte Corp.
and a Chief Executive Officer & Chief Medical Officer at Chronix Biomedical, Inc. He received his doctorate degree from the University of Gottingen.
Actieve functies van Ekkehard Schütz
| Bedrijven | Functie | Begin |
|---|---|---|
| ONCOCYTE CORPORATION | Chief Tech/Sci/R&D Officer | 01-04-2021 |
Chronix Biomedical, Inc.
 Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | Chief Executive Officer | - |
Opleiding van Ekkehard Schütz
| University of Gottingen | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ONCOCYTE CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Chronix Biomedical, Inc.
Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | Health Technology |
